Latest Biotech News

Recent studies have integrated artificial intelligence into reproductive medicine to improve ovarian reserve assessment and embryo classification. Hiroshi Koike's team applied advanced machine...

Organ transplantation practices are being advanced through techniques such as normothermic regional perfusion (NRP), which improves organ viability post circulatory death, particularly in liver...

Recent studies have compared the efficacy and outcomes of key diabetes treatments including Sodium-Glucose Cotransporter-2 (SGLT2) inhibitors, Glucagon-Like Peptide-1 (GLP-1) receptor agonists,...

Emerging research has illuminated the multifaceted roles of tumor cell-derived exosomes in cancer pathogenesis, diagnosis, and therapy, as reviewed by Li, Wang, Zhang et al. Complementing this,...

AI techniques have significantly enhanced diagnostic accuracy and therapeutic predictions across multiple domains. Liu et al. employed the XGBoost model for precise differentiation between primary...

Innovations in regenerative medicine highlight stem cell therapies as promising options for female reproductive disorders. Reviews and studies by Nair et al. and others elucidate their potential...

Recent pedagogical advancements in biomedical engineering education incorporate generative AI tools and targeted internship programs to better prepare students for industry demands. Innovations...

Sanofi has secured FDA approval for rilzabrutinib, a Bruton’s Tyrosine Kinase (BTK) inhibitor acquired through Principia Biopharma, marking a key advancement in immunology treatments. This...

Recent studies have illuminated AI's transformative role across biomedical fields, from enhancing embryo classification with deep learning frameworks like EmbryoNet-VGG16 to automating clinical...

Emerging therapies and comparative studies are reshaping diabetes and metabolic disease management. Empagliflozin demonstrates significant cardiovascular and renal benefits in obese type 2...

Cancer research progresses with targeted molecular insights and therapeutic strategies. Novel BTK inhibitors initiate apoptosis in tumor cells, providing promising avenues for hematological...

Advancements in organ transplantation focus on improving graft viability and outcomes. Normothermic regional perfusion (NRP) gains traction as a transformative technique in donation after...

Educational reforms in biomedical engineering emphasize experiential learning and industry alignment. Innovative curricula integrating curricular innovation and biodesign internships focus on...

The application of machine learning spans diverse domains from healthcare to agriculture. AI models improve ovarian reserve assessments and height prediction in pediatric growth disorders....

Cutting-edge cardiovascular research uncovers mechanistic insights and potential therapies. Studies identify FAT tissue biology changes as contributors to heart failure with preserved ejection...

The rare disease therapeutic landscape advances with new molecular agents and clinical trial successes. Sanofi’s rilzabrutinib gains FDA approval for immune thrombocytopenia, expanding treatment...

Recent investigations highlight critical dimensions of nursing and healthcare workforce development. Multicenter studies examine evidence-based practice competence among Turkish nurses and...

The FDA has approved Sanofi's rilzabrutinib, a Bruton’s Tyrosine Kinase (BTK) inhibitor acquired in the Principia Biopharma buyout, for treating immune thrombocytopenia (ITP). This approval marks...

Zephyr AI has acquired Aster Insights, gaining access to a longitudinal dataset of over 400,000 cancer patients, enhancing its capabilities in personalized oncology care. The combined data assets...

Researchers at UCLA developed AlloCAR70-NKT, an allogeneic CD70-directed CAR-NKT cell therapy designed for off-the-shelf use against metastatic renal cell carcinoma. This approach combines...